SPRO Historical PE Ratio image   This SPRO PE ratio history page last updated 5/22/2024
SPRO PE History Chart
PeriodPriceGAAPTTMPE
Q1 2024
5/15/2024
1.62-0.240.433.8
Q4 2023
3/13/2024
1.660.960.424.0
Q3 2023
11/13/2023
1.11-0.060.01111.0
Q2 2023
8/10/2023
1.45-0.230.0720.7
Q1 2023
5/11/2023
1.92-0.25-0.03NA
Q4 2022
3/30/2023
1.440.55-0.29NA
Q3 2022
11/14/2022
2.03-0.33-2.75NA
Q2 2022
8/10/2022
0.85-0.51-3.12NA
Q1 2022
5/16/2022
1.71-1.01-3.24NA
Q4 2021
3/31/2022
8.70-0.90-2.89NA
Q3 2021
11/10/2021
17.02-0.70-2.67NA
Q2 2021
8/5/2021
14.18-0.63-2.83NA
Q1 2021
5/6/2021
12.75-0.66-3.05NA
Q4 2020
3/11/2021
17.92-0.68-3.61NA
Q3 2020
11/5/2020
13.89-0.86-4.25NA
Q2 2020
8/6/2020
12.69-0.85-4.34NA
Q1 2020
5/8/2020
11.78-1.22-4.23NA
Q4 2019
3/16/2020
5.27-1.32-3.30NA
Q3 2019
11/4/2019
10.71-0.95-2.58NA
Q2 2019
8/8/2019
9.41-0.74-2.23NA
Q1 2019
5/9/2019
11.38-0.29-2.18NA
Q4 2018
3/14/2019
12.98-0.60-2.63NA
Q3 2018
11/8/2018
9.18-0.60-3.62NA
Q2 2018
8/9/2018
11.30-0.69-39.04NA
Q1 2018
5/10/2018
11.59-0.74NANA
Q4 2017
4/2/2018
14.20-1.59NANA
Q3 2017
12/14/2017
11.43-36.02NANA
SPRO Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q1 2024
5/15/2024
1.62-0.24-0.96NA
Q4 2023
3/13/2024
1.660.963.840.4
Q3 2023
11/13/2023
1.11-0.06-0.24NA
Q2 2023
8/10/2023
1.45-0.23-0.92NA
Q1 2023
5/11/2023
1.92-0.25-1.00NA
Q4 2022
3/30/2023
1.440.552.200.7
Q3 2022
11/14/2022
2.03-0.33-1.32NA
Q2 2022
8/10/2022
0.85-0.51-2.04NA
Q1 2022
5/16/2022
1.71-1.01-4.04NA
Q4 2021
3/31/2022
8.70-0.90-3.60NA
Q3 2021
11/10/2021
17.02-0.70-2.80NA
Q2 2021
8/5/2021
14.18-0.63-2.52NA
Q1 2021
5/6/2021
12.75-0.66-2.64NA
Q4 2020
3/11/2021
17.92-0.68-2.72NA
Q3 2020
11/5/2020
13.89-0.86-3.44NA
Q2 2020
8/6/2020
12.69-0.85-3.40NA
Q1 2020
5/8/2020
11.78-1.22-4.88NA
Q4 2019
3/16/2020
5.27-1.32-5.28NA
Q3 2019
11/4/2019
10.71-0.95-3.80NA
Q2 2019
8/8/2019
9.41-0.74-2.96NA
Q1 2019
5/9/2019
11.38-0.29-1.16NA
Q4 2018
3/14/2019
12.98-0.60-2.40NA
Q3 2018
11/8/2018
9.18-0.60-2.40NA
Q2 2018
8/9/2018
11.30-0.69-2.76NA
Q1 2018
5/10/2018
11.59-0.74-2.96NA
Q4 2017
4/2/2018
14.20-1.59-6.36NA
Q3 2017
12/14/2017
11.43-36.02-144.08NA
Quotes delayed 20 minutes

Email EnvelopeFree SPRO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Spero Therapeutics (SPRO) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

SPRY PE Ratio History
SQL PE Ratio History
SQZ PE Ratio History
SRDX PE Ratio History
SRGA PE Ratio History
SRNE PE Ratio History
SRPT PE Ratio History
SRRA PE Ratio History
SRRK PE Ratio History
SRTS PE Ratio History
On this page we presented the SPRO PE Ratio History information for Spero Therapeutics' stock. The average SPRO PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 0.6. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average SPRO PE ratio history based on this TTM earnings result method is 34.9. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this SPRO PE ratio history result, against the recent PE: when this page was posted on 5/21/2024, the most recent closing price for SPRO had been 1.51, and the most recent quarterly earnings result, annualized, was 3.84. Meanwhile, the most recent TTM earnings summed to 0.43. From these numbers, we calculate the recent SPRO PE on 5/21/2024 based on annualized quarterly EPS was 0.4. Based on SPRO's history, that recent PE is low relative to the historical average, with the recent PE 33.3% lower than the historical average PE across our data set for Spero Therapeutics. Looking at the recent SPRO PE on 5/21/2024 based on TTM EPS, we calculate the ratio at 3.5. Based on SPRO's history, that recent PE is low relative to the historical average, with the recent PE 90.0% lower than the average PE across our Spero Therapeutics data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on SPRO or any other given stock, valuation analysis for SPRO can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Spero Therapeutics PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for SPRO. Thanks for visiting, and the next time you need to research SPRO PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: Institutional Holders of ROST, Institutional Holders of UDBI, Institutional Holders of ERUS.

 

SPRO PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.